Literature DB >> 26154636

Association between serum ferritin and lipid peroxidation in hemodialysis patients.

Liliana M Pedruzzi1, Ludmila Ferreira Medeiros de França Cardozo1, Renata F Medeiros1, Milena B Stockler-Pinto1, Denise Mafra1.   

Abstract

INTRODUCTION: Iron supplementation is one of the recommendations found in patients with chronic kidney disease (CKD), however, an overload of this mineral can contribute to oxidative stress, a condition closely related to the cardiovascular risk in these patients, as well as disease progression.
OBJECTIVE: The objective of this study was to investigate whether ferritin levels are associated with oxidative stress marker MDA in patients on hemodialysis (HD).
METHODS: Twenty HD patients (55.0 ± 15.2 years, time of dialysis 76.5 ± 46.3 months, BMI 23.6 ± 3.0 kg/m2) were compared with 11 healthy subjects (50.9 ± 8.0 years, BMI 23.8 ± 1.9 kg/m2). Malondialdehyde (MDA) was measured by reaction with thiobarbituric acid and routine biochemical data were obtained from medical records.
RESULTS: MDA levels were significantly higher in HD patients compared to the control group (13.2 ± 5.3 nmol/mL vs. 5.1 ± 2.7nmol/mL, p < 0.01). Twelve patients (60%) had ferritin values greater than the 500 ng/mL and there was a positive correlation between ferritin and MDA in HD (r = 0.66, p = 0.005, n = 17) patients.
CONCLUSION: The excess iron stores in HD patients results in increased lipid peroxidation, and consequently contributes to increased oxidative stress in these patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26154636     DOI: 10.5935/0101-2800.20150028

Source DB:  PubMed          Journal:  J Bras Nefrol        ISSN: 0101-2800


  2 in total

1.  Curcumin supplementation improves oxidative stress and inflammation biomarkers in patients undergoing hemodialysis: a secondary analysis of a randomized controlled trial.

Authors:  Livia Alvarenga; Ludmila F M F Cardozo; Beatriz O Da Cruz; Bruna R Paiva; Denis Fouque; Denise Mafra
Journal:  Int Urol Nephrol       Date:  2022-03-26       Impact factor: 2.266

Review 2.  Hypoxia-Inducible Factor and Its Role in the Management of Anemia in Chronic Kidney Disease.

Authors:  Joshua M Kaplan; Neeraj Sharma; Sean Dikdan
Journal:  Int J Mol Sci       Date:  2018-01-29       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.